Medsol (a part of Gulf Healthcare International) announced today that its Al Abbar Laboratory has achieved JCIA accreditation. The achievement marks Al Abbar out as one of the few labs in the world to receive flawless accreditation from JCIA.
According to JCIA terminology not a single ''non conformance to the laid criteria for lab standards'' was observed during the audit procedure. Al Abbar also has ISO 15189 accreditation and is the latest Medsol lab to achieve international accreditation standards.
Mark Adams, CEO, Gulf Healthcare International said; ''Al Abbar's accreditation is the culmination of a series of efforts to ensure quality results are delivered to clients by each lab in the Medsol network. We plan to have all the Medsol labs accredited in the near future.
''Our vision is to have labs that conform to the best quality standards and deliver value to our clients and partners. Medsol is at the forefront of pathological testing in the MENA and the group's intention has always been to implement the best international practices into the region's diagnostic sector. We are pleased to say this is another step forward in that direction.''
The Joint Commission International (JCI) is the world leading accreditation agency for hospitals, ambulatory care facilities, clinical laboratories, care continuum services, medical transport organizations, and primary care services, as well as certification for disease or condition specific care. The international accreditation standards for clinical laboratories where formulated with extensive international input, and reflect, in content and organization, the most comprehensive standards for quality clinical laboratory services. They support a complete, accurate and objective assessment of laboratory processes and management practices. In meeting them the laboratory demonstrates its efficiency and accuracy in patient testing.
- Ends -
About Medsol and Gulf Healthcare International
Medsol is a part of Gulf Healthcare International (GHI). Medsol provides pathology testing services via a network of independent and hospital laboratories across the MENA region. Medsol presently has 15 operational labs across MENA - nine in UAE, five in Kuwait and one in KSA. As part of the aggressive growth plans, Medsol plans to have about 20 operational labs across the MENA in 2009.
GHI is a healthcare management company based in Dubai and operating in the Middle East and North Africa (MENA) region. The company's charter is to use international best practices in management to provide high quality and specialized healthcare to the people of the region.
For more information please contact:
Samantha Armstrong at The PR Company
Tel +971 501582958
Samantha@the-prcompany.com
© Press Release 2010
